1Sommer S, Wilkinson SM, English JS, et al. Type-IV hypersensitivity to betamethasone valerate and clobetasol propionate: results of a multicentre study. Br J Dermatol, 2002, 147(2): 266-269.
2Jacob SE, Steele T. Corticosteroid classes: a quick reference guide including patch test substances and cross-reactivity. J Am Acad Dermatol, 2006, 54(4): 723-727.
3Keegel T, Saunders H, Milne R, et al. Topical corticosteroid allergy in an urban Australian centre. Contact Dermatitis, 2004, 50(1): 6-14.
4Dooms-Goossens A. Sensitisation to corticosteroids. Consequences for anti-inflammatory therapy. Drug Saf, 1995, 13(2): 123-129.
5Degreef H, Dooms-Goossens A. The new corticosteroids: are they effective and safe?. Dermatol Clin, 1993, 11 ( 1 ): 155-160.
6Klein-Gitelman MS, Pachman LM. Intravenous corticosteroids: adverse reactions are more variable than expected in children. J Rheumatol, 1998,25(10): 1995-2002.
7Isaksson M. Corticosteroids. Dermatol Ther, 2004, 17(4): 314-320.
8Miranda-Romero A, Sanchez-Sambucety P, Bajo C, et al. Genital oedema from contact allergy to prednicarbate. Contact Dermatitis, 1998, 38(4): 228-229.
9Isaksson M, Bruze M. Repetitive usage testing with budesonide in experimental nickel--allergic contact dermatitis in individuals hypersensitive to budesonide. Br J Dermatol, 2001, 145 ( 1 ): 38-44.
10Isaksson M, Bruze M. Allergic contact dermatitis in response to budesonide reactivated by inhalation of the allergen. J Am Acad Dermatol, 2002, 46(6): 880-885.
